Despite the flood of lawsuits across the country stemming from Yaz and Yasmin injuries, the U.S. Food and Drug Administration (FDA) could not issue a clear statement on the dangers of the oral contraceptive. According to a story at usatoday.com, the FDA said that it only “remains concerned” about the risk of blood clots in women taking contraceptives that contain drospirenone, like Yaz and Yasmin.
The FDA study showed that there is a 50 percent increased risk of blood clots in women who take pills that contain drospirenone. The report points out that overall, the risk of blood clots is relatively small at 10 women for every 10,000 users of the contraceptive at risk of health problems.
As we have told you in many blog posts here, thousands of plaintiffs allege that Yaz and Yasmin caused blood clots and other serious health problems, including a fatality when a college girl died from a blood clot allegedly caused by the contraceptive.
Doctors prescribed Yaz and Yasmin for off-label uses such as clearing mild cases of acne. An allegation at the heart of the personal injury lawsuits is that Yaz and Yasmin were never approved for such off-label uses. Experts advise women to stop taking the pill immediately and consult a doctor if they experience any health problem.
Harrell & Nowak, L.L.C. – New Orleans accident attorneys